Sitero Acquires StudyOS, Launches AI-Powered CRO Platform
Sitero, a technology-enabled Clinical Research Organization (CRO), at this time introduced it has acquired the AI belongings and enterprise of studyOS – a novel eClinical AI know-how supplier and creator of Ash – the AI Clinical Trial Agent.
The transaction marks one other milestone in Sitero’s mission to deeply combine superior know-how with operational excellence throughout the scientific growth spectrum. The acquisition reinforces Sitero’s technique to mix modern, regulation-ready AI options with best-in-class service supply—making a unified atmosphere the place automation, analytics, and oversight converge to enhance pace, high quality and compliance in international scientific trials.
With this acquisition, Sitero is launching SiteroAITM to turn into the business’s first really AI-enabled CRO, providing AI-powered merchandise which are already in use by clients and delivering important, measurable effectivity positive aspects throughout real-world research. With the mix of studyOS and Sitero’s Mentor eClinical platform, SiteroAITM expects to ship 20–30% effectivity positive aspects throughout the scientific growth lifecycle for its clients in 2026, considerably bettering time-to-market and decreasing general research prices, whereas bettering information high quality.
Through the addition of studyOS’s Ash platform, Sitero will lengthen the capabilities of its Mentor eClinical suite and intensive scientific companies to supply sponsors a really clever AI working framework that accelerates each section of the trial lifecycle — from research design and web site activation by information evaluation, monitoring, and closeout. Ash’s natural-language interface permits groups to question, automate, and optimize trial workflows in actual time, driving measurable effectivity positive aspects throughout Data Management, Clinical Operations, and Sponsor Oversight actions.
The integration of studyOS additionally strengthens Sitero’s rising portfolio of AI-driven instruments geared toward empowering sponsors and CRO companions to make quicker, data-backed choices and cut back cycle occasions. The studyOS workforce, together with key technical and AI engineering personnel, will be part of Sitero to make sure a seamless transition, continuity of innovation, and sustained momentum in delivering next-generation capabilities that rework how research are executed globally.
“We strongly imagine within the potential for purpose-built AI to be a transformative software for our business,” stated Sankesh Abbhi, CEO of Sitero. “The studyOS platform is one in every of few options which have particularly constructed their AI intelligence from the bottom as much as clear up key challenges in our business. With this acquisition, I’m assured that our companions won’t solely get entry to business main know-how, however may also understand the cost-savings, efficiencies and high quality enhancements from our enhanced AI options.”
“Joining Sitero permits us to scale our AI imaginative and prescient throughout the total scientific trial lifecycle,” stated Ellis Butterfield, CEO of studyOS. “Our workforce is obsessed with how AI can allow novel workflows that really impression research timelines. By combining our Ash platform with Sitero’s Mentor eClinical suite, we will ship a unified, AI-powered atmosphere that drives measurable efficiencies throughout information administration, scientific operations, and sponsor oversight. Together, we’re not solely advancing the tempo of scientific analysis, but additionally redefining how know-how and intelligence converge to streamline execution and decision-making for sponsors worldwide.”
As a part of the acquisition, Ellis Butterfield can be serving as Sitero’s Chief Technology Officer (CTO), efficient instantly. Sitero plans to combine Ash into its proprietary Mentor eClinical suite, creating cross-system workflow capabilities that improve effectivity throughout a number of Mentor choices.
The submit Sitero Acquires StudyOS, Launches AI-Powered CRO Platform first appeared on AI-Tech Park.
